(2S,4R)-1-Boc-4-(tert-butyldimethylsilyloxy)-2-(hydroxymethyl)pyrrolidine
- Catalog No. :
- ACXFJD864
- CAS No. :
- 114676-67-4
- Molecular Formula :
- C16H33NO4Si
- Molecular Weight :
- 331.53
IUPAC Name:tert-butyl (2S,4R)-4-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)pyrrolidine-1-carboxylate
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$51.00Login to see priceIn stockInquiry
250mg95%$61.00Login to see priceIn stockIn stock
1g95%$148.00Login to see priceIn stockIn stock
5g95%$489.00Login to see priceIn stockIn stock
25g95%$1931.00Login to see priceInquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | (2S,4R)-1-Boc-4-(tert-butyldimethylsilyloxy)-2-(hydroxymethyl)pyrrolidine |
|---|---|
| IUPAC Name | tert-butyl (2S,4R)-4-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)pyrrolidine-1-carboxylate |
| MDL No. | MFCD08752960 |
| Molecular Formula | C16H33NO4Si |
| Molecular Weight | 331.53 |
| SMILES | O=C(N1[C@H](CO)C[C@@H](O[Si](C)(C(C)(C)C)C)C1)OC(C)(C)C |
| InChI Key | IIITUHPEBILIQR-QWHCGFSZSA-N |
| Synonym | (2S,4R)-1-Boc-4-(tert-butyldiMethylsilyloxy)-2-(hydroxyMethyl)pyrrolidine;4-(tert-Butyl-dimethyl-silanyloxy)-2-hydroxymethyl-pyrrolidine-1-carboxylic acid;(2S,4R)-tert-Butyl 4-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)pyrrolidine-1-carboxylate;(2S,4R)-1-Boc-4-[(t-butyldimethylsilyl)oxy]-2-(hydroxymethyl)pyrrolidine;1-Pyrrolidinecarboxylic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-(hydroxymethyl)-, 1,1-dimethylethyl ester, (2S,4R)-;tert-Butyl (2S,4R)-4-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)pyrrolidine-1-carboxylate;"(2S,4R)-4-(tert-butyldimethylsilyloxy)-1-(tert-butoxycarbonyl)-2-hydroxymethylpyrrolidine";(2S,4R)-N-Boc-trans-4-OTBS-L-prolinol |
| CAS No. | 114676-67-4 |
Safety Data
- Pictogram
- Signal Word
- Achtung
- Hazard Statement(s)
- H302-H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338
